Recherche
-
Characterization of the novel HLA-B*18:204 allele by sequencing-based typing
(HLA: Immune Response Genetics. vol. 98, n° 2, pp. 157-158, 2021)Article de revue -
Characterization of the novel HLA-A*36:12 allele by sequencing-based typing
(HLA: Immune Response Genetics. vol. 98, n° 1, pp. 51-53, 2021-05-24)Article de revue -
Characterization of the novel HLA-C*16:173 allele by sequencing-based typing
(HLA: Immune Response Genetics. vol. 97, n° 1, pp. 82-83, 2021-01)Article de revue -
Characterization of the novel HLA-DPA1*01:61 allele by sequencing-based typing
(HLA: Immune Response Genetics, 2021-12)Article de revue -
Characterization of the novel HLA-DQB1*06:385 allele by sequencing-based typing
(HLA: Immune Response Genetics. vol. 98, pp. 73-574. d, 2021)Article de revue -
Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases
(Joint Bone Spine. vol. 88, n° 6, 2021-05-26)Article de revue -
Eurolupus cyclophosphamide plus repeated pulses of methyl-prednisolone for the induction therapy of class III, IV and V lupus nephritis
(AUTOIMMUNITY REVIEWS. vol. 20, n° 10, 2021)Article de revue -
Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target?
(Biochimica et Biophysica Acta - Reviews on Cancer. vol. 1876, n° 2, 2021)Article de revue -
Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors
(Cancer Immunology, Immunotherapy. vol. 71, n° 11, pp. 2609-2618, 2022-11)Article de revue -
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study
(European Journal of Clinical Pharmacology. vol. 78, n° 12, pp. 1981-1990, 2022-10-26)Article de revue